During the past decade, Tom Baker Cancer Centre conducted 217 clinical trials. In the 10-year time frame, 217 clinical trials started and 148 clinical trials were completed, i.e. on average, 68.2% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 78 clinical trials were completed. i.e. 102.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tom Baker Cancer Centre" #1 sponsor was "NCIC Clinical Trials Group" with 51 trials, followed by "Radiation Therapy Oncology Group" with 49 trials sponsored, "AHS Cancer Control Alberta" with 29 trials sponsored, "National Cancer Institute (NCI)" with 29 trials sponsored and "Canadian Cancer Trials Group" with 29 trials sponsored. Other sponsors include 375 different institutions and companies that sponsored additional 124 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tom Baker Cancer Centre" #1 collaborator was "National Cancer Institute (NCI)" with 127 trials as a collaborator, "NCIC Clinical Trials Group" with 30 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator and "Tom Baker Cancer Centre" with 16 trials as a collaborator. Other collaborators include 370 different institutions and companies that were collaborators in the rest 188 trials.

According to Clinical.Site data, the most researched conditions in "Tom Baker Cancer Centre" are "Prostate Cancer" (41 trials), "Breast Cancer" (40 trials), "Multiple Myeloma" (34 trials), "Ovarian Cancer" (29 trials) and "Lung Cancer" (19 trials). Many other conditions were trialed in "Tom Baker Cancer Centre" in a lesser frequency.

Most popular intervention types in "Tom Baker Cancer Centre" are "Drug" (448 trials), "Radiation" (110 trials), "Other" (76 trials), "Procedure" (74 trials) and "Biological" (61 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (53 trials), "Placebo" (47 trials), "Dexamethasone" (27 trials), "cisplatin" (27 trials) and "Laboratory Biomarker Analysis" (22 trials). Other intervention names were less common.

The vast majority of trials in "Tom Baker Cancer Centre" are 404 trials for "All" genders, 107 trials for "Female" genders and 53 trials for "Male" genders.

Currently, there are NaN active trials in "Tom Baker Cancer Centre". 3 are not yet recruiting, 65 are recruiting, 112 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 315 completed trials in Tom Baker Cancer Centre, 1 suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Tom Baker Cancer Centre, 56 "Phase 1" clinical trials were conducted, 215 "Phase 2" clinical trials and 270 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 40 trials that are defined as “Not Applicable".